Psychopharmacology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 26, 2024
Despite
the
growing
scientific
interest
on
mitragynine,
primary
alkaloid
in
kratom
(Mitragyna
Speciosa),
there
is
a
lack
of
clinical
trials
humans.
This
phase
1
study
aimed
to
evaluate
mitragynine's
safety
profile
and
acute
effects
subjective
drug
experience,
neurocognition,
pain
tolerance.
A
placebo-controlled,
single-blind,
within-subjects
was
conducted
two
parts.
In
part
A,
eight
healthy
human
volunteers
received
placebo
three
doses
mitragynine
(5,
10,
20
mg)
sequential
dosing
scheme,
separate
days.
B,
second
group
seven
40
mg
mitragynine.
Vital
signs,
neurocognitive
function,
tolerance
were
measured
at
regular
intervals
for
7
h
after
administration.
Overall,
did
not
affect
most
outcome
measures
any
dose.
Yet,
lowest
dose
(5
increased
ratings
arousal
attention,
accuracy
sustained
attention
task,
motor
inhibition.
The
highest
(40
amnesia
produced
mild
psychopathological
symptoms.
Mitragynine
significantly
vital
only
mild,
transient
side
reported.
present
suggests
that
low
(5–10
may
cause
feelings
stimulation
enhance
while
inhibitory
distress.
up
well
tolerated
this
group.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: June 3, 2024
Although
kratom
use
has
been
part
of
life
for
centuries
in
Southeast
Asia,
the
availability
and
United
States
(US)
increased
substantially
since
early
2000s
when
there
was
little
information
on
pharmacology,
patterns,
effects,
all
critical
to
guiding
regulation
policy.
Here
we
provide
a
synthesis
research
with
several
hundred
English-language
papers
published
past
5
years
drawing
from
basic
research,
epidemiological
surveillance
data,
recent
clinical
research.
This
review
available
literature
aims
an
integrated
update
regarding
our
current
understanding
kratom’s
benefits,
risks,
epidemiology,
which
may
inform
States-based
regulation.
Recent
indicates
are
likely
million
past-year
consumers,
though
estimates
vary
widely.
Even
without
precise
prevalence
is
no
longer
niche,
millions
adults
using
it
myriad
reasons.
Despite
its
botanical
origins
coffee
tree
family
polypharmacy,
popularly
characterized
as
opioid
presumed
opioid-system-based
risks
addiction
or
overdose.
Neuropharmacology,
toxicology,
epidemiology
studies
show
that
more
accurately
substance
diverse
complex
pharmacology.
Taken
together
work
reviewed
here
provides
foundation
future
scientific
studies,
well
guide
ongoing
efforts
regulate
kratom.
also
informs
much-needed
federal
oversight,
including
by
Food
Drug
Administration.
We
conclude
recommendations
priorities
needed
address
policy
knowledge
gaps
around
this
increasingly
used
product.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: June 14, 2024
Background
“Kratom”
refers
to
an
array
of
bioactive
products
derived
from
Mitragyna
speciosa
,
a
tree
indigenous
Southeast
Asia.
Most
kratom
consumers
report
analgesic
and
stimulatory
effects,
common
reasons
for
use
are
address
mental
physical
health
needs,
manage
pain,
reduce
other
substances.
Natural-history
studies
survey
suggest
that
many
perceive
benefits
those
uses,
but
such
unlikely
capture
the
full
range
kratom-use
experiences.
Methods
We
collected
text
data
Reddit
posts
2020-2022
qualitatively
examine
conceptualizations,
motivations,
consequences
associated
with
among
people
posting
social
media.
mentioning
were
studied
using
template
thematic
analysis,
which
included
collecting
descriptions
product
types
practices.
Network
analyses
coded
themes
was
performed
independent
relationships
themes,
between
types.
Results
Codes
applied
329
370
comprised
final
sample;
134
contained
descriptions.
As
accounts
functionally
anonymous,
demographic
estimates
untenable.
Themes
dependence
(tolerance,
withdrawal,
or
avoid
withdrawal),
perceived
addiction
(net
detrimental
effects
on
functioning),
quitting.
Extract
positively
reports
addiction,
dependence,
experiences
quitting
kratom.
Many
used
energy
self-treatment
fatigue,
problems
opioid
alcohol;
they
these
uses
as
effective.
Consumers
expressed
frustrations
about
inconsistencies
lack
information.
Conclusion
in
previous
studies,
deemed
helpful
some
hindrance
others,
we
also
found
evidence
notable
negative
have
not
been
well
documented
surveys.
Daily
may
produce
mild-moderate
greater
severity
being
possibly
more
concentrated
extracts;
however,
there
currently
no
human
laboratory
extracts.
Such
detailed
information,
needed
help
inform
consumer
decision-making.
µ-Opioid
receptors
are
pivotal
in
mediating
the
analgesic
and
addictive
properties
of
opioid
drugs.
(−)-Mitragynine,
a
natural
alkaloid,
is
known
for
its
effects
functions
as
G
protein-biased
ligand
at
µ-opioid
receptor.
However,
molecular-level
understanding
receptor-mitragynine
interactions
remains
unclear.
This
study
examined
structural
alterations
receptor
upon
binding
with
(−)-mitragynine,
(+)-mitragynine,
7-OH-mitragynine,
morphine
using
molecular
docking
1
µs
classical
all-atom
dynamics
simulations
lipid
membranes.
Our
results
showed
that
(−)-mitragynine
(-7.2
Kcal/mol)
7-OH-mitragynine
(-7.8
have
higher
affinities
than
(-6.78
Kcal/mol).
The
remained
relatively
stable
during
dynamics,
though
residues
260-280
exhibited
notable
fluctuations.
(−)-Mitragynine
formed
hydrogen
bonds
more
consistently
other
ligands
throughout
simulation
period.
Asp-147
played
critical
role
formation
salt
bridge
positively
charged
amino
group
all
ligands,
which
key
interaction
orthosteric
typical
receptors.
All
four
preferentially
interacted
Trp-293
helix-6,
highlighting
activation.
A
plot
free
energy
versus
helix-6
tilt
angle
distance
between
tertiary
nitrogen
revealed
distinct
conformational
population
compared
to
mitragynine,
may
explain
their
different
downstream
signaling
bias.
unique
patterns
mitragynine
derivatives
receptor,
providing
foundation
designing
novel
potentially
developing
new
analgesics.
Home Healthcare Now,
Journal Year:
2025,
Volume and Issue:
43(2), P. 122 - 124
Published: Feb. 28, 2025
The
author
declares
no
conflicts
of
interest.
Address
for
correspondence:
Heidi
Sykora,
DNP,
RN,
GNP-BC
(retired),
2321
Ridgewood
Rd.,
Grafton,
WI
53024.
Journal of Psychoactive Drugs,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 9
Published: March 1, 2025
With
increasing
diversity
of
kratom
(Mitragyna
speciosa
Korth.)
products
containing
higher
amounts
alkaloids
including
mitragynine
and
7-hydroxymitragynine,
safety
becomes
a
public
concern.
The
study
aimed
to
estimate
the
prevalence
use
examine
potential
benefits
adverse
effects
based
on
product
formulations.
A
cross-sectional
survey
utilized
non-probabilistic
nationally
representative
sampling
with
total
11,545
respondents
which
1,049
reported
current
use,
indicating
9.1%
prevalence.
most
common
used
in
past
30
days
were
pills,
gummies
powder
Pain
relief
(n
=
603,
57.5%)
was
condition
for
using
kratom,
followed
by
relaxation/stress
562,
53.6%)
boost
energy
520,
49.6%).
increased
from
tea
bags
improved
sleep
leaf
or
extract
powders.
significant
positive
correlation
found
between
frequency
consuming
shots/extract
pain
(p
.009
0.015,
respectively.
incidence
as
amount
per
dose
gummies/capsules/tablets/pills.
lack
standardization
consistency
results
unpredictable
effects,
emphasizing
need
research
establish
reliable
guidelines
dosage
recommendations.
Frontiers in Public Health,
Journal Year:
2024,
Volume and Issue:
12
Published: May 30, 2024
Substance
use
disorders
contribute
to
considerable
U.S.
morbidity
and
mortality.
While
effective
pharmacotherapy
options
are
available
treat
opioid
alcohol
disorders,
for
a
variety
of
reasons,
many
patients
lack
access
treatment
or
may
be
reluctant
seek
care
due
concerns
such
as
perceived
stigma
current
desire
completely
curtail
their
substance
use.
Furthermore,
limited
with
stimulant
polysubstance
disorders.
Thus,
there
is
need
expand
the
disorder
harm
reduction
armamentarium.
Kratom
(
Mitragyna
speciosa
Korth.)
an
herbal
that
can
produce
both
stimulant-like
effects,
its
in
US
growing.
Though
regarding
adverse
dependence
risk,
regulation
manufacturing
sale,
pharmacology
kratom
early
preclinical
studies
suggest
potential
role
agent
various
it
has
historically
been
used
Southeast
Asia
purposes.
The
goal
this
review
describe
kratom’s
history
use,
pharmacology,
pre-clinical
observational
research
therapeutic
disorder,
well
alcohol,
stimulant,
while
also
highlighting
around
existing
gaps
literature,
directions
future
research.
Traditionally
used
in
Southeast
Asia
for
common
ailments,
kratom
(Mitragyna
speciosa)
is
increasingly
being
adopted
other
regions
the
self-treatment
of
pain,
mental
health
issues
such
as
anxiety,
depression,
and
dependence
or
managing
withdrawal
symptoms
linked
to
stimulants/sedatives
substances
absence
clinical
supervision.
To
gain
better
insight
into
experiences
motivations
underlying
use,
previous
studies
have
analyzed
material
shared
among
users
on
social
media.
However,
these
investigations
often
employed
manual
labeling
categorizations,
which
are
time-consuming
do
not
allow
investigation
large
samples.
The
present
work
utilized
a
natural
language
processing
approach
(BERTopic)
extract
prominent
topics
discussion
from
kratom-related
Reddit
posts
made
between
2010
2023
(n
=
188,139
posts).
Dynamic
Topic
Modeling
was
also
implemented
analyze
how
discussions
about
evolved
over
time.
From
results,
discussed
including
usage
substance
use
disorder
recovery
(e.g.,
suboxone),
drug
testing,
consumption
methods,
logistic
bringing
flights,
receiving
via
mail),
tapering
off
kratom,
providing
support
others
who
process
quitting
kratom.
current
study
supports
need
trials
well
new
ecological
insights
users,
while
supporting
implementation
policies
regulate
its
usage.
Drug and Alcohol Dependence,
Journal Year:
2024,
Volume and Issue:
264, P. 112460 - 112460
Published: Oct. 10, 2024
Using
ecological
momentary
assessment
(EMA),
we
undertook
a
natural
experiment
wherein
kratom-product
variability
was
tool
to
assess
kratom
dose-response
relationships
based
on
product
form
and
alkaloid
level.